altretamine has been researched along with vindesine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonomi, PD; Ettinger, D; Mason, B; Pazdur, R; Stolbach, L | 1 |
| Alberto, P; Cavalli, F; Joss, RA; Jungi, WF; Obrecht, JP; Sauter, C | 1 |
| Daugaard, G; Hansen, HH; Rørth, M | 1 |
| Durie, BG; Salmon, SE | 1 |
| Brunner, KW; Goldhirsch, A; Joss, RA | 1 |
| Carter, SK | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
2 review(s) available for altretamine and vindesine
| Article | Year |
|---|---|
The current status and future prospects of treatment for multiple myeloma.
Topics: Acute Kidney Injury; Altretamine; Anemia; Bacterial Infections; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Hypercalcemia; Interferons; Kidney Failure, Chronic; Melphalan; Meningeal Neoplasms; Multiple Myeloma; Spinal Cord Compression; Vinblastine; Vincristine; Vindesine | 1982 |
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
1 trial(s) available for altretamine and vindesine
| Article | Year |
|---|---|
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
6 other study(ies) available for altretamine and vindesine
| Article | Year |
|---|---|
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Vindesine | 1986 |
Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Topics: Altretamine; Antineoplastic Agents; Carcinoma, Small Cell; Drug Therapy, Combination; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Mitomycins; Vinblastine; Vindesine | 1982 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |